Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

Conditions

• Arrythmia
• Asthma
• COPD Exacerbation
• Cardiac Event
• Critical Illness
• Gastrointestinal Diseases
• Heart Failure
• Hematologic Diseases
• Infections
• Neurologic Disorder
• Oncology Problem
• Renal Disease
• Renal Failure
• Rheumatic Diseases
• Shock
• Urologic Diseases

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Health Information Exchange (HIE) platform — OTHER
  An improved health information exchange (HIE) platform will be developed at the start of the study with key stakeholder input. This platform will be implemented for use after baseline data collection, and will allow for improved data exchange between transferring and accepting hospital. We will allow for a 6-month wash-in period prior to intervention data collection.

Study Details

Sub-optimal transfer of clinical information during inter-hospital transfer (IHT, the transfer of patients between acute care hospitals) is common and can lead to patient harm. To address this problem, the investigators will use key stakeholder input to refine and implement an interoperable health information exchange platform that integrates with the electronic health record and improves the reliability of and access to necessary clinical information in three use cases involving transfer of patients between sending and receiving hospitals with varying levels of affiliation and health record integration. The investigators will assess the effect of this intervention on frequency of medical errors, evaluate the use and usability of this platform from the perspective of those that interact with it, and use these results to develop a dissemination plan to spread implementation and use of this platform across other similar institutions.

Key Dates

Start date

Nov 1, 2022

Status verified

Jan 2026

Primary completion

Dec 22, 2025

Completion

Jun 30, 2027

Study Design

Enrollment

1,006 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

SEQUENTIAL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• No Intervention: Baseline
  The baseline arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year pre-intervention phase. They will not receive any intervention, but rather usual care
• Experimental: Intervention
  The intervention arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year intervention phase. They will receive the intervention, which will include utilization of the developed health information exchange platform to transfer clinical information between transferring and accepting hospital. The intervention will not interact directly with the patient, but rather their clinical data.

Primary Outcome Measure

Total clinician-reported medical errors [ Time Frame: Up to 72 hours after transfer ]

Locations (1)

Find similar trials in Boston, MA

Related Studies

• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  Recruiting · Medtronic · Birmingham, Alabama
• Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
  PHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts
• Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
  Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
• Diffusion MRI in Heart Failure
  EARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts